Data: 08/08/2026
Total encontrado: 6
1/6US=65 / Biol/Mol
D'Alessio S, Blasi F. The urokinase plasminogen activator receptor as a target for cancer therapy. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 223-43. ISBN 978-0-387-69056-8.

RECEPTOR UROQUINASE; ATIVADOR DO PLASMINOGENIO; TERAPIA DO CANCER; SISTEMA UPA/UPAR; TRANSDUCAO DE SINAL; MOTILIDADE CELULAR; PROLIFERACAO CELULAR; CANCER; ESTRATEGIAS TERAPEUTICAS ANTISENSE; APOPTOSE

2/6US=65 / Biol/Mol
Ragno P, Blasi F. uPAR and proteases in mobilization of hematopoietic stem cells. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 433-50. ISBN 978-0-387-69056-8.

UPAR; PROTEASES; CELULAS ESTAMINAIS HEMATOPOIETICAS

3/6US=65 / Biol/Mol
Zamai M, Malengo G, Caiolfa VR. Measuring uPAR dynamics in live cells. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 475-93. ISBN 978-0-387-69056-8.

UPAR; MEDICAO DINAMICA; CELULAS VIVAS; RECEPTORES DE ATIVADOR DE PLASMINOGENIO TIPO UROQUINASE

4/6US=65 / Biol/Mol
Christensen IJ, Pappot H, Hoyer-Hansen G. The plasminogen activation system as a source of prognostic markers in cancer. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 569-86. ISBN 978-0-387-69056-8.

SISTEMA DE ATIVACAO DO PLASMINOGENIO; MARCADORES; PROGNOSTICO NO CANCER; UPA; UPAR; PAI-1; CANCER DE MAMA; CANCER COLORRETAL; CANCER DE PULMAO; CANCER GINECOLOGICO; CANCER DE PROSTATA

5/6US=65 / Biol/Mol
Jacobsen B, Kjaergaard M, Gardsvoll H, Ploug M. Structure and inhibition of the urokinase-type plasminogen activator receptor. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 699-719. ISBN 978-0-387-69056-8.

ATIVADOR DO PLASMINOGENIO TIPO UROQUINASE; UPAR; ANTICORPOS MONOCLONAIS; ANTAGONISTAS PEPTIDICOS

6/6US=246 / Tese/FAP
Anelli A. Determinação da relação entre a expressão do sistema de ativação do plasminogênio e o prognóstico em câncer de mama feminino localmente avançado. [Relationship between the expression of plasminogen activation system and prognosis in locally advanced female breast cancer]. São Paulo, 2009. 46 p. Tese(Doutorado)-Fundação Antônio Prudente.

Disponível em: http://accamargo.phlnet.com.br/Doutorado/2009/us246.pdf

Curriculum Lattes

CANCER DE MAMA; QUIMIOTERAPIA; ATIVADORES DE PLASMINOGENIO; PROGNOSTICO; TISSUE ARRAY